Literature DB >> 9180190

Increased c-fos expression in the brain during experimental murine cerebral malaria: possible association with neurologic complications.

N Ma1, A J Harding, R Pamphlett, G Chaudhri, N H Hunt.   

Abstract

Cerebral expression of c-fos protein was studied by immunocytochemistry in murine cerebral malaria (CM) and malaria without cerebral involvement (non-CM). c-fos expression, low in the brains of uninfected mice, increased in frequency, intensity, and distribution during the course of fatal CM (e.g., a 70-fold increase on day 7 after inoculation). These changes paralleled the timing and degree of the neurologic complications and histopathologic changes. Only a slight increase in c-fos expression was detectable in non-CM mice on day 7 after inoculation. Dexamethasone treatment (days 0 and 1 after inoculation) of the CM mice largely prevented the increased cerebral c-fos expression, histopathologic changes, cerebral complications, and death. Increased c-fos expression may indicate the specific neuronal pathways activated by the immunopathologic process of fatal murine CM and could be associated with the behavioral changes and neurologic complications in this model.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180190     DOI: 10.1086/516483

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM).

Authors:  Sripada Santosh Anand; Mulaka Maruthi; Phanithi Prakash Babu
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

3.  Nogo-A expression in the brain of mice with cerebral malaria.

Authors:  Peter Lackner; Ronny Beer; Gregor Broessner; Raimund Helbok; Karolin Dallago; Michael W Hess; Kristian Pfaller; Christine Bandtlow; Erich Schmutzhard
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

4.  Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study.

Authors:  Rafal S Sobota; Antoine Dara; Jessica E Manning; Amadou Niangaly; Jason A Bailey; Abdoulaye K Kone; Mahamadou A Thera; Abdoulaye A Djimdé; Guy Vernet; Philippe Leissner; Scott M Williams; Christopher V Plowe; Ogobara K Doumbo
Journal:  Malar J       Date:  2016-03-09       Impact factor: 2.979

5.  Bone marrow-derived mesenchymal stem cell and simvastatin treatment leads to improved functional recovery and modified c-Fos expression levels in the brain following ischemic stroke.

Authors:  Gila Pirzad Jahromi; Alireza P Shabanzadeh; Mina Mokhtari Hashtjini; Seyed Shahabeddin Sadr; Javad Rasouli Vani; Javad Raouf Sarshoori; Jason Charish
Journal:  Iran J Basic Med Sci       Date:  2018-10       Impact factor: 2.699

Review 6.  Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis.

Authors:  Teresa F Pais; Carlos Penha-Gonçalves
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

7.  Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.

Authors:  Peter Lackner; Andrea Part; Christoph Burger; Anelia Dietmann; Gregor Broessner; Raimund Helbok; Markus Reindl; Erich Schmutzhard; Ronny Beer
Journal:  Malar J       Date:  2009-02-27       Impact factor: 2.979

8.  Immune system challenge improves recognition memory and reverses malaria-induced cognitive impairment in mice.

Authors:  Luciana Pereira de Sousa; Flávia Lima Ribeiro-Gomes; Roberto Farina de Almeida; Tadeu Mello E Souza; Guilherme Loureiro Werneck; Diogo Onofre Souza; Cláudio Tadeu Daniel-Ribeiro
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.

Authors:  Peter Lackner; Christian Hametner; Ronny Beer; Christoph Burger; Gregor Broessner; Raimund Helbok; Cornelia Speth; Erich Schmutzhard
Journal:  Malar J       Date:  2008-10-10       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.